| Average Daily Range |
| Avg Daily Range: |
$0.15 | 6.03%
|
| Avg Daily Range (30 D): |
$0.00 | 50.00%
|
| Avg Daily Range (90 D): |
$0.01 | 50.00%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
6.82M |
| Avg Daily Volume (30 D): |
.35M |
| Avg Daily Volume (90 D): |
1.88M |
| Trade Size |
| Avg Trade Size (Sh.): |
779 |
| Avg Trade Size (Sh.) (30 D): |
9,590 |
| Avg Trade Size (Sh.) (90 D): |
21,677 |
| Institutional Trades |
| Total Institutional Trades: |
15 |
| Avg Institutional Trade: |
$1.4M |
| Avg Institutional Trade (30 D): |
$.93M |
| Avg Institutional Trade (90 D): |
$.93M |
| Avg Institutional Trade Volume: |
.2M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.01M |
| Avg Closing Trade (30 D): |
$.93M |
| Avg Closing Trade (90 D): |
$.93M |
| Avg Closing Volume: |
464.32K |
|
|
| News |
Nov 22, 2024 @ 9:45 PM
Ocean Biomedical, Inc. Announces Receipt of Notice...
Source: N/A
|
Oct 22, 2024 @ 8:45 PM
Ocean Biomedical, Inc. Announces Receipt of Nasdaq...
Source: N/A
|
Oct 1, 2024 @ 12:01 PM
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Pu...
Source: Ocean Biomedical
|
Jun 5, 2024 @ 11:01 AM
Ocean Biomedical (NASDAQ: OCEA) Congratulates Join...
Source: Ocean Biomedical, Inc.
|
May 30, 2024 @ 11:44 AM
Ocean Biomedical, Inc. Announces Receipt of Notice...
Source: Ocean Biomedical, Inc.
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-.09
|
$-.05
|
$-.34
|
|
Diluted EPS
|
$-.09
|
$-.05
|
$-.34
|
|
Revenue
|
$M
|
$-.43M
|
$-2.05M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-8.24M
|
$-1.54M
|
$-9.48M
|
|
Operating Income / Loss
|
$-.96M
|
$-1.75M
|
$-3.8M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-.36M
|
$M
|
$M
|
|
PE Ratio
|
|
|
|
|
|
|
